0001415889-18-000948.txt : 20180618 0001415889-18-000948.hdr.sgml : 20180618 20180618160022 ACCESSION NUMBER: 0001415889-18-000948 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180617 FILED AS OF DATE: 20180618 DATE AS OF CHANGE: 20180618 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CASEY MICHAEL D CENTRAL INDEX KEY: 0001190435 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34912 FILM NUMBER: 18904517 MAIL ADDRESS: STREET 1: ALLOS THERAPEUTICS, INC. STREET 2: 11080 CIRCLEPOINT ROAD, SUITE 200 CITY: WESTMINSTER STATE: CO ZIP: 80020 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CELGENE CORP /DE/ CENTRAL INDEX KEY: 0000816284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222711928 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: (908)673-9000 MAIL ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 4 1 form4-06182018_040606.xml X0306 4 2018-06-17 0000816284 CELGENE CORP /DE/ CELG 0001190435 CASEY MICHAEL D C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 true false false false Common Stock 2018-06-17 4 M 0 334 0 A 0 D Common Stock 117813 I By Family Trust Restricted Stock Unit 2018-06-17 4 M 0 334 0 D Common Stock 334 0 D The remaining one-third of the restricted stock units granted to the reporting person on June 17, 2015 vested and settled for shares of the Company's common stock. 334 shares were transferred to the Casey Family Trust U/A Dated 12/28/2004. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the Company's 2008 Stock Incentive Plan). /s/ Peter N. Kellogg, Attorney-in-Fact 2018-06-18